分子量：Calculated MW: 18kDa/19kDa/24kDa
Observed MW: 24kDa

細胞定位：Cytoplasm, Membrane, Nucleus, Nucleus, Peripheral membrane protein

稀釋方法：WB 1:500 - 1:2000
IHC 1:50 - 1:200
IF 1:50 - 1:200

總結：Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.